Comprehensive coverage

Biotechnology in Israel

ALS disease. Illustration: shutterstock

Immunity Pharma announces the start of a clinical study in ALS patients with the original drug IPL344

  • No comments
In the photo from the right: Mark Feiglin - director of scouting and partnerships at the Merck Group in Israel, Suderson Sinha from Tel Aviv University, mentor Gael Waiche - from the Merck Group in Germany, Max Kushner from the Weizmann Institute, Daoud Shaban from the Weizmann Institute. Photo: Liat Elder.

Technology for accurate counting of bacterial colonies won the Merck hackathon in Israel

  • One response
MassChallenge. Photo: Sean Zinsmeister, flickr.

Messchallenge distributed prizes totaling about one million shekels to the winning companies in the first round of the acceleration program in Israel

  • No comments
Experiments on animals. Photo: shutterstock

University research vice presidents call for halting laws that would make animal testing impossible

  • 23 תגובות
Dr. Inbar Freeman, CEO of Bio-Neggev, and Dr. Shay Yarkoni, Chairman of Bio-Neggev. PR photo

Biotechnology Cluster: Maged Bio-Negev was officially inaugurated with six companies; 11 patents for Nixoa, LapSpace and Neuroderm recruit chicken-feeding robot

  • No comments
An energy transfer system for an artificial heart by Leviticos. PR photo

Biotechnology cluster: Levitas Cardio recruits; And also on: Protlix, Yes Fit, Redhill Biopharma, Compugen and a joint venture with Germany in the field of biotechnology

  • No comments
Businesswoman Siegel Weissasser, representative of the Chinese government at a conference dealing with business with China, October 2013

There is a very narrow window of opportunity for business between Israel and China in the biotechnological, pharmaceutical and medical equipment aspects

  • One response
Biotechnology. Illustration: shutterstock

Biotechnology Cluster: Pluristem received the approval of the US Registrar for a key patent of the company

  • No comments
Dr. Marina Scogniamilio, head of the Italian Trade Commission (ICE) operating in Tel Aviv

International interest in the biomed industry and medical devices in Israel - large delegations from Germany and Italy participated in IATI-biomed

  • No comments
IATI-Biomed 2013 conference logo

President Obama's personal adviser on scientific affairs, among the participants at the IATI Biomed 2013 conference

  • No comments
NMR scan of the brain of a 15-year-old boy suffering from glioblastoma brain cancer. From Wikipedia

The International Conference on Personalized Medicine returns to be hosted in Israel

  • No comments

The Dutch investment fund BOM Capital is coming to Israel - looking for technology and biomed companies

  • One response
Dr. Avi Treves, Sheba Medical Center

Ahead of the Israestem conference: Israel should invest in the field of regenerative medicine and stem cells, in order to maintain its leadership against countries that have decided to promote the field

  • No comments
Robotic surgery at Rambam Hospital, 2011

Dr. Yair Erez, economist at McKinsey London: The model of a patient coming to the doctor with symptoms will not last.

  • 3 תגובות
An example of a micelle used to deliver a drug. The blue atoms are the hydrophilic end of the polymer, while the white atoms are the hydrophobic end. The red atoms symbolize the drug/active substance atoms. Such a system can also be used to transfer food materials and various additives, apart from medicines. [Source: www.atrp.gatech.edu/pt18-3/18-3_p3]

Polypid, a developer of products for the local release of drugs, raised $2.4 million in a third funding round

  • One response
Biotechnology - Figure: American Standards Institute NIST

57% increase in the number of biotechnology companies

  • No comments
The ReWalk system developed by Argo allows amputees to walk on their own;

Biotech cluster: Clover begins a clinical trial, Ergo Medical expands

  • One response
A doctor uses an endoscope. NIH photo

Doctors in Israel - publish a lot, are cited less

  • 3 תגובות
From the left: Prof. Michel Rebel from the Weizmann Institute, Prof. Vladas Bomlis - Honorary Consul of Lithuania in Israel, CEO of Enterprise Lithuania and next to him the Minister of Economy of Lithuania Rymantas Zhilios at the opening of the Life Sciences Baltics 2012 conference. Photo: Avi Blizovsky

"The 21st century is the century of biotechnology"

  • 3 תגובות
The chief scientist at TMT, Dr. Avi Hasson

Four Israeli projects in the field of life sciences will be funded in the amount of 3 million dollars

  • One response
Dr. Anat Cohen-Dig, CEO of Compugen

Compugen and Mark Sarono's venture capital fund are jointly establishing Neviah Genomics) a new company for the discovery and development of diagnostic markers

  • No comments
Safra Square and Jerusalem Municipality Building. From Wikipedia

A new venture capital fund - Boril Israel is on its way to the biomed industry in Jerusalem

  • No comments
The Doctor, painting by Sir Luke Fields, 1891

Make a high wave

  • 3 תגובות
Biomed-2012 logo

15 delegations including senior officials from the global life sciences industry will arrive in Israel for a week at Yomed as guests of the Ministry of Science and Technology

  • No comments
Lizzy-Shoub London, partner and manager at Niche Biotech

"Niche" survey ahead of Israel Biomed week 2012: an increase of about 20% in the demand for workers in the fields of chemistry in the biomed industry

  • 3 תגובות
Science website logo
SEARCH